{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:21:10Z","timestamp":1780104070025,"version":"3.54.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,11]],"date-time":"2012-11-11T00:00:00Z","timestamp":1352592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00296-012-2571-5","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T11:59:30Z","timestamp":1352548770000},"page":"1409-1413","source":"Crossref","is-referenced-by-count":20,"title":["Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept"],"prefix":"10.1007","volume":"33","author":[{"given":"Xiaohu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,11]]},"reference":[{"key":"2571_CR1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00296-011-1938-3","volume":"32","author":"EM Silva","year":"2011","unstructured":"Silva EM, Andrade SC, Vilar MJ (2011) Evaluation of the effects of Global Postural Reeducation in patients with ankylosing spondylitis. Rheumatol Int 32:2155\u20132163","journal-title":"Rheumatol Int"},{"key":"2571_CR2","first-page":"613","volume":"27","author":"A Zink","year":"2000","unstructured":"Zink A, Braun J, Listing J, Wollenhaupt J (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis\u2014results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 27:613","journal-title":"J Rheumatol"},{"key":"2571_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00296-009-0973-9","volume":"29","author":"L Goh","year":"2009","unstructured":"Goh L, Samanta A (2009) A systematic medline analysis of therapeutic approaches in ankylosing spondylitis. Rheumatol Int 29:1123\u20131135","journal-title":"Rheumatol Int"},{"key":"2571_CR4","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/art.11017","volume":"48","author":"J Brandt","year":"2003","unstructured":"Brandt J, Khariouzov A, Listing J, Haibel H, S\u00f6rensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J (2003) Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48:1667\u20131675","journal-title":"Arthritis Rheum"},{"key":"2571_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00296-009-1157-3","volume":"30","author":"AR Giardina","year":"2010","unstructured":"Giardina AR, Ferrante A, Ciccia F, Impastato R, Miceli MC, Principato A, Triolo G (2010) A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis. Rheumatol Int 30:1437\u20131440","journal-title":"Rheumatol Int"},{"key":"2571_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/keh475","volume":"44","author":"J Brandt","year":"2005","unstructured":"Brandt J, Listing J, Haibel H, S\u00f6rensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J (2005) Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology 44:342\u2013348","journal-title":"Rheumatology"},{"key":"2571_CR7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00296-011-1920-0","volume":"32","author":"J Moghimi","year":"2011","unstructured":"Moghimi J, Sheikhvatan M, Semnani V (2011) The use of low-dose etanercept as an alternative therapy for treatment of ankylosing spondylitis: a case series. Rheumatol Int 32:2271\u20132274","journal-title":"Rheumatol Int"},{"key":"2571_CR8","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00296-011-1844-8","volume":"32","author":"F Lian","year":"2011","unstructured":"Lian F, Yang X, Liang L, Xu H, Zhan Z, Qiu Q, Ye Y (2011) Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int 32:1663\u20131667","journal-title":"Rheumatol Int"},{"key":"2571_CR9","first-page":"1482","volume":"17","author":"MB Ferraz","year":"1990","unstructured":"Ferraz MB, Tugwell P, Goldsmith C, Atra E (1990) Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 17:1482","journal-title":"J Rheumatol"},{"key":"2571_CR10","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/art.1780391209","volume":"39","author":"DO Clegg","year":"1996","unstructured":"Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, Mahowald ML, Schumacher HR Jr, Taylor T, Budiman-Mak E (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39:2004\u20132012","journal-title":"Arthritis Rheum"},{"key":"2571_CR11","unstructured":"Huang F, Wei J, Breban M (2002) Thalidomide in ankylosing spondylitis. Clinical and experimental rheumatology 20:158\u2013161"},{"key":"2571_CR12","first-page":"2627","volume":"30","author":"JCC Wei","year":"2003","unstructured":"Wei JCC, Chan TW, Lin HS, Huang F, Chou CT (2003) Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol 30:2627\u20132631","journal-title":"J Rheumatol"},{"key":"2571_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0889-857X(03)00028-0","volume":"29","author":"JC Davis","year":"2003","unstructured":"Davis JC, Huang F, Maksymowych W (2003) New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate. Rheum Dis Clin North Am 29:481\u2013494","journal-title":"Rheum Dis Clin North Am"},{"key":"2571_CR14","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286","journal-title":"J Rheumatol"},{"key":"2571_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/art.20414","volume":"51","author":"MA Stone","year":"2004","unstructured":"Stone MA, Inman RD, Wright JG, Maetzel A (2004) Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics. Arthritis Care Res (Hoboken) 51:316\u2013320","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2571_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/art.21588","volume":"53","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos X, Brandt J, Listing J, Haibel H, S\u00f6rensen H, Rudwaleit M, Sieper J, Braun J (2005) Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Care Res (Hoboken) 53:856\u2013863","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2571-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2571-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:26:19Z","timestamp":1562678779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2571-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2571-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,11]]}}}